{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:52Z","timestamp":1790702212784,"version":"4.1.0"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2023,7,20]]},"DOI":"10.18632\/oncotarget.28476","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T06:56:32Z","timestamp":1689836192000},"page":"723-737","source":"Crossref","is-referenced-by-count":3,"title":["The uncharacterized transcript\n                    <i>KIAA0930<\/i>\n                    confers a cachexic phenotype on cancer cells"],"prefix":"10.18632","volume":"14","author":[{"given":"Takahiro","family":"Yamakawa","sequence":"first","affiliation":[{"name":"Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza Bengrine","family":"Najjar","sequence":"additional","affiliation":[{"name":"Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[{"name":"Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Itakura","sequence":"additional","affiliation":[{"name":"Center for RNA Biology and Therapeutics, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"20503121211034366","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: Current perspectives","volume":"9","author":"Manyazewal","year":"2021","journal-title":"SAGE Open Med"},{"key":"2","first-page":"155","article-title":"Targeted Cancer Therapies","volume":"10","author":"Prasad","year":"2021","journal-title":"Am Fam Physician"},{"key":"3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-022-02287-3","article-title":"Targeted therapies for cancer","volume":"2","author":"Li","year":"2022","journal-title":"BMC Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial","volume":"40","author":"Linardou","year":"2023","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.2147\/DDDT.S267433","article-title":"Research Status and Outlook of PD-1\/PD-L1 Inhibitors for Cancer Therapy","volume":"1","author":"Yang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"6","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3390\/cancers11121863","article-title":"IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1\/2 Axis to Induce Muscle Atrophy","volume":"1","author":"Judge","year":"2019","journal-title":"Cancers (Basel)"},{"key":"7","doi-asserted-by":"publisher","first-page":"e20190450","DOI":"10.1084\/jem.20190450","article-title":"Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia","volume":"21","author":"Liu","year":"2021","journal-title":"J Exp Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cellsig.2016.01.010","article-title":"Transforming growth factor type beta (TGF-\u03b2) requires reactive oxygen species to induce skeletal muscle atrophy","volume":"2","author":"Cabello-Verrugio","year":"2016","journal-title":"Cell Signal"},{"key":"9","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"30","author":"Zimmers","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00111.2012","article-title":"Rel A\/p65 is required for cytokine-induced myotube atrophy","volume":"30","author":"Kandarian","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"C706","DOI":"10.1152\/ajpcell.00626.2008","article-title":"Interleukin-1 stimulates catabolism in C2C12 myotubes","volume":"29","author":"Reid","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jcsm.12251","article-title":"Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na\u00efve pancreatic cancer patients","volume":"9","author":"Hart","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"13","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia","volume":"29","author":"Jackman","year":"2015","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"S\u00f8rhaug","year":"2017","journal-title":"Sci Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jcsm.12565","article-title":"The expression landscape of cachexia-inducing factors in human cancers","volume":"1","author":"Carvalho","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcsm.12402","article-title":"Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review","volume":"1","author":"Anker","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4103\/apjon.apjon-2145","article-title":"Understanding Cachexia in Head and Neck Cancer","volume":"8","author":"Muthu","year":"2021","journal-title":"Asia Pac J Oncol Nurs"},{"key":"18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-016-0317-z","article-title":"Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting","volume":"3","author":"Yuan","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"e13604","DOI":"10.1371\/journal.pone.0013604","article-title":"Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition","volume":"5","author":"Costelli","year":"2010","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.18632\/oncotarget.13593","article-title":"Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia","volume":"8","author":"Trevino","year":"2017","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"publisher","first-page":"e0132786","DOI":"10.1371\/journal.pone.0132786","article-title":"TGF-\u03b2 Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia","volume":"1","author":"Rendon","year":"2015","journal-title":"PLoS One"},{"key":"22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mus.22232","article-title":"Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis","volume":"4","author":"Brooks","year":"2012","journal-title":"Muscle Nerve"},{"key":"23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"59","author":"Kohl","year":"2021","journal-title":"Nature"},{"key":"24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes","volume":"30","author":"Sonnhammer","year":"2001","journal-title":"J Mol Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","article-title":"SignalP 6.0 predicts all five types of signal peptides using protein language models","volume":"4","author":"Nielsen","year":"2022","journal-title":"Nat Biotechnol"},{"key":"26","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gr.193540.115","article-title":"CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins","volume":"2","author":"Myers","year":"2015","journal-title":"Genome Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nmeth1170","article-title":"Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies","volume":"5","author":"Wang","year":"2008","journal-title":"Nat Methods"},{"key":"28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/acschembio.7b00549","article-title":"CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide","volume":"1","author":"Wood","year":"2018","journal-title":"ACS Chem Biol"},{"key":"29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"2","author":"Muscaritoli","year":"2008","journal-title":"Clin Nutr"},{"key":"30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fonc.2020.00298","article-title":"Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options","volume":"1","author":"Calore","year":"2020","journal-title":"Front Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/rco2.30","article-title":"Mediators and clinical treatment for cancer cachexia: a systematic review","volume":"4","author":"Osellame","year":"2021","journal-title":"JCSM Rapid Communications"},{"key":"32","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.3390\/cancers14174258","article-title":"Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes","volume":"1","author":"Taneja","year":"2022","journal-title":"Cancers (Basel)"},{"key":"33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jcsm.12550","article-title":"Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle","volume":"1","author":"Judge","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"34","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","article-title":"Modeling Human Cancer-induced Cachexia","volume":"2","author":"Timmers","year":"2019","journal-title":"Cell Rep"},{"key":"35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1152\/physiol.00017.2010","article-title":"Pathways for cytokine secretion","volume":"2","author":"Lacy","year":"2010","journal-title":"Physiology (Bethesda)"},{"key":"36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejcb.2018.06.003","article-title":"A comprehensive review of signal peptides: Structure, roles, and applications","volume":"9","author":"Ghasemi","year":"2018","journal-title":"Eur J Cell Biol"},{"key":"37","doi-asserted-by":"publisher","first-page":"jcs213686","DOI":"10.1242\/jcs.213686","article-title":"Unconventional protein secretion - new insights into the pathogenesis and therapeutic targets of human diseases","volume":"13","author":"Lee","year":"2018","journal-title":"J Cell Sci"},{"key":"38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tcb.2016.11.007","article-title":"Pathways of Unconventional Protein Secretion","volume":"2","author":"Rabouille","year":"2017","journal-title":"Trends Cell Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41589-020-00698-y","article-title":"Cell type-selective secretome profiling","volume":"1","author":"Long","year":"2021","journal-title":"Nat Chem Biol"},{"key":"40","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/cancers13092147","article-title":"Exosomes in Liquid Biopsy: The Nanometric World in the Pursuit of Precision Oncology","volume":"1","author":"Montuenga","year":"2021","journal-title":"Cancers (Basel)"},{"key":"41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"4","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12033-014-9815-4","article-title":"Universal real-time PCR-based assay for lentiviral titration","volume":"5","author":"Kulcenty","year":"2015","journal-title":"Mol Biotechnol"},{"key":"43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/pros.23699","article-title":"AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells","volume":"7","author":"Itakura","year":"2018","journal-title":"Prostate"},{"key":"44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/pros.24251","article-title":"AT-rich interaction domain 5A regulates the transcription of interleukin-6 gene in prostate cancer cells","volume":"8","author":"Yamakawa","year":"2022","journal-title":"Prostate"},{"key":"45","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Zhang","year":"2013","journal-title":"Nat Protoc"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T05:56:28Z","timestamp":1689918988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,20]]}},"alternative-id":["28476"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28476","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}